Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
Clinical trial NCT01865812 · COMPLETED
Trial details
- NCT number
- NCT01865812
- Sponsor
- Intercept Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-03
- Primary completion
- 2014-08-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.